Reverse transcriptase (RT)-PCR: Principles, Applications

A 28-year-old woman presents to a hospital in Delhi with five days of high fever, severe headache, and joint pain. The clinician suspects dengue. A rapid NS1 antigen test is negative — but the test is most sensitive in the first 24–48 hours of illness, and five days have passed. A dengue IgM test is ordered — but at day five of illness the patient is at the very edge of the IgM detection window, and even a positive result cannot identify the serotype, which matters for assessing severe dengue risk on secondary infection. The laboratory runs an RT-PCR on her serum.

The result returns positive for dengue virus serotype 2. The confirmation changes management — the team now knows the exact causative virus, rules out other arboviruses in the differential, and can report the serotype to the district health surveillance system.

Why RT-PCR and not standard PCR? Because dengue virus, like all flaviviruses, has an RNA genome. Standard PCR amplifies DNA. There is no dengue DNA to amplify. RT-PCR solves this by first converting the viral RNA into complementary DNA (cDNA) using the enzyme reverse transcriptase — then amplifying that cDNA using standard PCR. Without the reverse transcription step, dengue, HIV, hepatitis C, influenza, and SARS-CoV-2 would all be invisible to PCR.

Reverse Transcriptase PCR (RT-PCR) is a variation of the polymerase chain reaction that amplifies target RNA. Addition of reverse transcriptase (RT) enzyme prior to PCR makes it possible to amplify and detect RNA targets.

Reverse transcriptase enzyme transcribes the template RNA and forms complementary DNA (cDNA). Single-stranded cDNA is converted into double-stranded DNA using DNA polymerase. These DNA molecules can now be used as templates for a PCR reaction.

Nowadays, single thermostable DNA polymerase that also possesses significant reverse transcriptase activity is used in the single-step reaction.

Why RT-PCR Matters in Clinical Microbiology

The majority of clinically important emerging and re-emerging pathogens have RNA genomes. HIV, hepatitis C virus, dengue, influenza, SARS-CoV-2, Ebola, West Nile virus, enteroviruses — all are RNA viruses. Standard PCR cannot detect them directly because it requires a DNA template. RT-PCR bridges this gap.

Beyond virus detection, RT-PCR has two additional clinical applications that distinguish it from DNA-based PCR:

Detecting viable organisms: DNA persists in dead cells. A patient who was successfully treated for tuberculosis may still carry residual mycobacterial DNA detectable by standard PCR weeks after effective therapy. RNA, by contrast, degrades rapidly after an organism dies. Detecting mycobacterial rRNA by RT-PCR is more likely to indicate the presence of viable, active organisms than detecting mycobacterial DNA — clinically important when assessing treatment response.

Gene expression analysis: mRNA is produced only when a gene is actively transcribed. Detecting mRNA by RT-PCR confirms that a gene is being expressed — not just present in the genome. This is used in microbiology research (studying virulence gene expression) and in clinical oncology (detecting fusion transcripts in leukaemia, confirming expression of resistance genes in bacteria).

Principle of RT-PCR

Reverse transcription and PCR amplification can be performed as a two-step process in a single tube or with two separate reactions. In both cases, RNA is first reverse-transcribed into cDNA, which is then used as the template for PCR amplification.

The primers used for cDNA synthesis can be either non–sequence-specific primers (a mixture of random hexamers or oligo-dT primers) or sequence-specific primers.

• Non-sequence-specific primers:

Random hexamers are a mixture of all possible combinations of six nucleotide sequences that can attach randomly to mRNA and initiate reverse transcription of the entire RNA pool. Oligo-dT primers are complementary to the poly-A tail of mRNA molecules and allow synthesis of cDNA only from mRNA molecules.

• Sequence-specific primers:

Sequence-specific primers are the most restricted because they are designed to bind selectively to mRNA molecules of interest, which makes reverse transcription a target-specific process.

Figure: One-step and two-step methods of RT- PCR.

RT-PCR vs. Real-time PCR: Clearing the Most Common Confusion

These two terms are the single most frequently confused concepts in molecular diagnostics — including among healthcare workers. The confusion intensified during the COVID-19 pandemic, when "RT-PCR test" was used by governments, media, and health authorities to describe the SARS-CoV-2 diagnostic test — a test that is actually RT-qPCR (combining both methods).

The one-line rule: RT-PCR tells you what the starting material is (RNA). Real-time PCR tells you how detection happens (fluorescence in real time). A test can be both simultaneously — and modern viral diagnostics usually are.

One-step RT-PCR

cDNA synthesis and PCR are performed in a single reaction vessel in a common reaction buffer. Gene-specific primers direct cDNA synthesis and amplification of a specific target. Major advantages of one-step reaction include minimal sample handling, reduced bench time, and closed-tube reactions, reducing chances for pipetting errors and cross-contamination.

The quality and scarcity of RNA samples impact the efficiency of one-step RT-PCR. The cDNA synthesis product cannot be saved after one-step RT-PCR so additional aliquots of the original RNA sample(s) are required in order to repeat reactions or to assess the expression of other genes.

Two-step RT-PCR

In two-step RT-PCR, cDNA synthesis is carried out using random hexamers, oligo-dT primers, and/or gene-specific primers which gives a mixture of cDNA molecules. cDNAs thus synthesized are amplified using specific primers.

In two-step RT-PCR, cDNA is synthesized in one reaction, and an aliquot of the cDNA is then used for a subsequent PCR experiment. This requires extra open-tube step, more pipetting manipulations, and longer hands-on time which may lead to greater variability and risk of contamination. Remaining cDNA can be stored for future use, or quantitating the expression of multiple genes from a single RNA/cDNA sample.

One-step vs. Two-step RT-PCR: Summary Comparison

Applications

Many clinically important viruses have genomes composed of RNA, RT-PCR is useful for detecting such viruses. RT-PCR has also been used for the detection of the viral causes of meningitis and meningoencephalitis, such as enteroviruses and the West Nile virus. RT-PCR is being used for the detection of the following viruses:

1. Dengue virus
2. Hantavirus
3. Human metapneumovirus
4. Severe acute respiratory syndrome (SARS)

Quantitative RT-PCR assays are commonly used for the detection of HIV and HCV viral load (amount of these viruses present in the blood of a patient) testing.

Viral load data are important for monitoring the response of the individual patient to therapy. For instance, after appropriate antiretroviral therapy, patient infected with HIV virus should demonstrate an increase in CD4 count and a decrease in HIV viral load.

RT-PCR may also be used to detect other microorganisms (bacteria, parasites, and fungi) by targeting their rRNA. This approach is better than detection of DNA, as the presence of RNA is more likely associated with the presence of viable organisms.

Detection of mRNA using RT-PCR helps to study the gene expression of both microorganisms and human host cells.

How to Remember

RT-PCR = reverse gear before forward. Standard PCR reads DNA in the forward direction — template to copy. Reverse transcriptase runs in reverse — it reads RNA and writes DNA (cDNA). RT-PCR adds this reverse gear step at the beginning so that RNA targets can be fed into the standard PCR engine. Without the reverse gear, RNA viruses are invisible.

RNA viruses need RT; DNA viruses do not. HIV, HCV, dengue, influenza, SARS-CoV-2, enteroviruses — all RNA genomes, all require RT-PCR. Herpes simplex, CMV, EBV, adenovirus — all DNA genomes, standard PCR is sufficient. When the question names an RNA virus and asks which PCR is used, the answer is RT-PCR.

One-step = fast and clean; two-step = flexible and reusable. One-step is the clinical diagnostic choice — minimal handling, lower contamination risk, faster result. Two-step is the research choice — the cDNA library can be stored and queried for multiple genes from a single RNA sample. Think: one-step for the emergency lab; two-step for the research bench.

Primer choice for cDNA synthesis:

• Random hexamers → amplify everything (all RNA in the sample)
• Oligo-dT primers → amplify only mRNA (bind poly-A tail)
• Gene-specific primers → amplify only the target RNA

The more specific the primer, the more targeted — but also the more restricted — the cDNA synthesis.

RT-PCR detects viable organisms; DNA PCR cannot. RNA degrades after cell death; DNA persists. For treatment monitoring where distinguishing live from dead organisms matters, RT-PCR targeting rRNA is the better tool.

Key exam facts in one table

References and Further Reading

1. Mahon, C. R., Lehman, D. C., & Manuselis, G. (2018). Textbook of Diagnostic Microbiology (6th ed.). Elsevier.
2. Murray, P. R., Rosenthal, K. S., & Pfaller, M. A. (2021). Medical Microbiology (9th ed.). Elsevier.
3. Bustin, S. A., Benes, V., Garson, J. A., et al. (2009). The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry, 55(4), 611–622. https://doi.org/10.1373/clinchem.2008.112797
4. New England Biolabs. (2021). Choice of One-Step RT-qPCR or Two-Step RT-qPCR. https://www.neb.com/tools-and-resources/usage-guidelines/one-step-vs-two-step-rt-qpcr
5. Clinical and Laboratory Standards Institute (CLSI). (2016). Clinical Microbiology Procedures Handbook (4th ed.). American Society of Microbiology.